|

Vortioxetine Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 2: 1Phase 4: 1Phase 1/2: 1

Top Sponsors

  • University of Zurich1
  • Mayo Clinic1
  • First Affiliated Hospital of Chongqing Medical University1

Indications

  • Depression2
  • Sequestra1
  • Bipolar Depression1
  • Unipolar Depression1
  • Glioblastoma1

Other2 trials

Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
Phase 1/2
Vortioxetine for Newly Diagnosed Glioblastoma
Phase 2

Rochester, Minnesota1 trial

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

Mayo Clinic in Rochester

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.